Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Survey says: U.S. hospitals have big plans for automation

Nearly two-thirds of hospitals are hoping to implement robotic process automation and AI technologies in the next two years, according to a new survey of healthcare executives.

Thumbnail

Patients are comfortable with AI-powered cancer screening, but still want input from physicians

Patients are on board with AI-powered skin cancer screening, according to a new study published in JAMA Dermatology. But relationships with human physicians remain a priority.

Thumbnail

Trump sends drug pricing reform principles to Congress

President Trump has sent his wish list of drug pricing reform priorities to Capitol Hill.

Thumbnail

Industry reactions to interoperability rule are a mixed bag

A set of new rules that aim to improve the interoperability of healthcare records and set a string of new requirements on healthcare providers was met with mixed reactions across the industry.

Thumbnail

CVS Health acquires 110 Midwest pharmacies

CVS Pharmacy is acquiring 110 pharmacies in the Midwest through a definitive agreement to take over Schnuck Markets' retail and specialty pharmacy businesses. An acquisition price and other financial details were not disclosed.

CMS launches new model to lower insulin costs to $35

Seniors reliant on insulin may soon get a break when it comes to out-of-pocket expenses under a new Medicare Part D model that caps insulin costs at a $35 copay for a 30-day supply.

Thumbnail

CMS issues coronavirus guidance to healthcare providers

CMS has issued a guidance on the new coronavirus, COVID-19, for healthcare providers to stay up to date on the screening, treatment and transfer procedures to follow as well as how to better protect seniors in nursing homes. CMS also called on hospital emergency departments to screen for the disease when patients present symptoms.

Thumbnail

Operating in healthcare, AI could land someone in medicolegal limbo

If medical AI makes a goof and causes a patient harm, the provider using the technology may be liable for malpractice. Or will the AI vendor be on the hook?

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.